ULTRAMICROSIZE GRISEOFULVIN
- Product NDC
- 62135-501
- 11-digit product format
- 621350501
- Labeler code
- 62135
- Product ID
- 62135-501_2e9858c1-8c99-8a0d-e063-6294a90a59a5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ULTRAMICROSIZE GRISEOFULVIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA061996
- Marketing category
- ANDA
- Marketing start
- 1982-04-06
- Substance
- GRISEOFULVIN
- Active strength
- 165 mg/1
- Pharmacologic classes
- Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ULTRAMICROSIZE GRISEOFULVIN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GRISEOFULVIN | 165 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 32HRV3E3D5 |
| Rxcui | 245248 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-501-30 | ULTRAMICROSIZE GRISEOFULVIN | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-501 | ULTRAMICROSIZE GRISEOFULVIN TABLET [CHARTWELL RX, LLC] | 1 | Current NDC, 1 package rows | 20250223_640c489e-f491-4805-a390-ef4be43e261b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-501-30 | 62135050130 | 30 TABLET in 1 BOTTLE (62135-501-30) | 30 tablet | 2025-01-30 | No | No | Current |